Interleukin-10 promoter polymorphisms and liver fibrosis progression in patients with chronic hepatitis C in Japan [3]

Journal of Hepatology

Volumn 39, Issue 3, 2003, Pages 457-458

  Hamada, Hisayuki ^a,b   Yatsuhashi, Hiroshi ^a   Yano, Koji ^a   Arisawa, Kokichi ^b   Nakao, Kazuhiko ^b   Yano, Michitami ^a  

^a NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ADULT; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENETIC POLYMORPHISM; HAPLOTYPE; HEPATITIS C; HUMAN; HUMAN TISSUE; INHERITANCE; JAPAN; LETTER; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; POSTTRANSFUSION HEPATITIS; PRIORITY JOURNAL; PROMOTER REGION; RACE DIFFERENCE;

EID: 0041828182     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(03)00246-0     Document Type: Letter

References (5)

1. Pagliaro L, Peri V, Linea C, Camma C, Giunta M, Magrin S. Natural history of chronic hepatitis C. Ital J Gastroenterol Hepatol 1999;31:28-44.
2. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-1520.
3. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997;349:825-832.
4. Lim S, Crawley E, Woo P, Barnes PJ. Haplotype associated with low interleukin-10 production in patients with severe asthma. Lancet 1998;352:113.
5. Nelson DR, Lauwers GY, Lau JY, Davis GL. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon non-responders. Gastroenterology 2000;118:655-660.